[{"id":"2368e794-6a95-4b8e-bfab-f3ed9d06481c","acronym":"","url":"https://clinicaltrials.gov/study/NCT01955460","created_at":"2021-01-18T08:52:28.248Z","updated_at":"2024-07-02T16:35:08.687Z","phase":"Phase 1","brief_title":"Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma","source_id_and_acronym":"NCT01955460","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" NGFR • TGFA","pipe":" | ","alterations":" TILs","tags":["NGFR • TGFA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TILs"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • Proleukin (aldesleukin) • cyclophosphamide intravenous"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 10/15/2014","start_date":" 10/15/2014","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2024-04-19"},{"id":"f558dd72-ce2b-4a2b-8f9d-1822f6c0359b","acronym":"NCI-2014-02655","url":"https://clinicaltrials.gov/study/NCT01740557","created_at":"2021-01-18T07:37:08.655Z","updated_at":"2024-07-02T16:35:38.425Z","phase":"Phase 1/2","brief_title":"Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma","source_id_and_acronym":"NCT01740557 - NCI-2014-02655","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" CXCL8 • NGFR • CXCR2","pipe":"","alterations":" ","tags":["CXCL8 • NGFR • CXCR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • Proleukin (aldesleukin) • CXCR2 and NGFR transduced TIL • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 01/28/2015","start_date":" 01/28/2015","primary_txt":" Primary completion: 04/21/2023","primary_completion_date":" 04/21/2023","study_txt":" Completion: 04/21/2023","study_completion_date":" 04/21/2023","last_update_posted":"2023-08-31"},{"id":"6b954619-c29b-4daa-b767-be4fb2c7d5e0","acronym":"Bio2Treat","url":"https://clinicaltrials.gov/study/NCT04835779","created_at":"2021-04-08T13:52:35.747Z","updated_at":"2024-07-02T16:35:57.990Z","phase":"","brief_title":"Biometric and Biological Data for Diagnosis and Therapy of Pain Patients","source_id_and_acronym":"NCT04835779 - Bio2Treat","lead_sponsor":"RWTH Aachen University","biomarkers":" NGFR","pipe":" | ","alterations":" TFRC expression","tags":["NGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TFRC expression"],"overall_status":"Recruiting","enrollment":" Enrollment 68","initiation":"Initiation: 10/10/2020","start_date":" 10/10/2020","primary_txt":" Primary completion: 10/01/2023","primary_completion_date":" 10/01/2023","study_txt":" Completion: 10/01/2023","study_completion_date":" 10/01/2023","last_update_posted":"2023-01-09"}]